Searched for
TORRENT PHARMACEUTICALS EARNINGS REPORT
Torrent Pharmaceuticals Q1 Results: Profit rises 3% to Rs 566 croreTorrent Pharmaceuticals announced a robust profit after tax of Rs 566 crore for the first quarter, showcasing impressive growth. Revenue so...- ChrysCapital acquires controlling 70.68% stake in Novartis India listed unit in first majority pharma investmentChrysCapital has acquired a controlling interest in Novartis India Limited, representing its inaugural investment in India's pharmaceutical...
- Shell's Q2 profit more than doubles to $9.8 billion, beats estimatesShell reported a significant profit increase in the second quarter, reaching $9.84 billion. Higher energy prices and market volatility cont...
- Aswath Damodaran warns against disclosure diarrhoea. Why the valuation guru wants Wall Street to end quarterly earningsValuation expert Aswath Damodaran has criticised excessive quarterly disclosures, calling it “disclosure diarrhoea” that fuels short-termis...
- Qualcomm forecasts weak quarterly profit, expects Apple revenue drop to accelerateShares of the company were down more than 4% in extended trading on Wednesday, while Apple shares were flat.
- Microsoft set for $190 billion market value swing after earnings results, options indicateThe tech company's options imply a move of about 6.6% in either direction after the company reports fourth-quarter results. By comparison, ...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Global Markets: Japan's Nikkei rises as oil falls before key earningsJapan's Nikkei share average closed higher on Monday, boosted by lower oil prices. Investors remained cautious due to upcoming major earnin...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- Wall Street Week Ahead: US stocks face tests from Fed decision, tech-led earnings delugeInvestors await the Federal Reserve's interest rate decision and corporate earnings reports. Technology giants and artificial intelligence ...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 26%The US-Iran war continues to create uncertainty for markets across the globe. But more so in India, due to the high correlation between ene...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- Axis Bank among 5 F&O stocks with a sharp rise in futures open interestFive NSE F&O stocks, including Radico Khaitan, Torrent Pharma and Axis Bank, recorded over 6% growth in futures open interest, indicating f...
- Union Bank of India among 7 stocks flashing bullish signals, hinting at a possible uptrendOn July 20, seven stocks in the Nifty500 appeared on the 'White Marubozu' bullish scanner, according to StockEdge's technical scan data. Th...
Load More
